National report from Burnet and Kirby Institutes showing the latest hepatitis C data across Australia.
Rates of new hepatitis C infections have steadily declined since 2016. This is seen through reductions in incidence among people attending primary care clinics and a sample of people who inject drugs.
Since 2016, there’s been a decline in hepatitis C virus (HCV) ribonucleic acid (RNA) prevalence among a sample of people who inject drugs. HCV RNA is the genetic material of the hepatitis C virus found in a person’s blood.
Data from this year’s report show other promising signs, with increased testing seen in some settings including:
- primary care
- sexual health clinics
- Aboriginal Community Controlled Health Services.
